Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Long-Term Potentiation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Long-Term Potentiation is a biological pathway involved in neurodegeneration research. Key relationships include: activates, regulates, inhibits. Associated with ALS, Aging, Als. Connected to 113 entities in the SciDEX knowledge graph.
| Name | Long-Term Potentiation |
| Summary | Fixed References section |
| Key Genes/Proteins | NRG1, ALZHEIMER'S DISEASE, COMPLEMENT, AMYLOID, ALZHEIMER |
| Related Diseases | Alzheimer'S Disease, Learning and Memory, Learning And Memory, Alzheimer |
| Related Pathways | Nrg1-Erbb4 Signaling, Reduced Lactate Shuttling |
Knowledge base pages for this entity
graph TD
Long_Term_Potentiation["Long-Term Potentiation"] -->|"interacts"| Complement["Complement"]
Long_Term_Potentiation["Long-Term Potentiation"] -->|"interacts"| Autophagy["Autophagy"]
Long_Term_Potentiation["Long-Term Potentiation"] -->|"interacts"| Nf__b["Nf-Kappab"]
Long_Term_Potentiation["Long-Term Potentiation"] -->|"interacts"| Apoptosis["Apoptosis"]
Long_Term_Potentiation["Long-Term Potentiation"] -->|"interacts"| Synaptic_Plasticity["Synaptic Plasticity"]
Long_Term_Potentiation["Long-Term Potentiation"] -->|"interacts"| Calcium_Signaling["Calcium Signaling"]
JUN["JUN"] -->|"regulates"| Long_Term_Potentiation["Long-Term Potentiation"]
C1Q["C1Q"] -->|"associated"| Long_Term_Potentiation["Long-Term Potentiation"]
ANXA1["ANXA1"] -->|"therapeutic target"| Long_Term_Potentiation["Long-Term Potentiation"]
NBR1["NBR1"] -->|"therapeutic target"| Long_Term_Potentiation["Long-Term Potentiation"]
style Long_Term_Potentiation fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Learning and Memory | mediates | phenotype | 0.85 |
| Learning And Memory | associated_with | phenotype | 0.85 |
| Hippocampus | expressed_in | cell_type | 0.80 |
| Complement | interacts_with | pathway | 0.55 |
| Autophagy | interacts_with | pathway | 0.55 |
| Nf-Κb | interacts_with | pathway | 0.55 |
| Apoptosis | interacts_with | pathway | 0.55 |
| Synaptic Plasticity | interacts_with | pathway | 0.55 |
| Calcium Signaling | interacts_with | pathway | 0.55 |
| STRIATUM | interacts_with | concept | 0.50 |
| CEREBRAL CORTEX | interacts_with | concept | 0.50 |
| Protein Aggregation | activates | process | 0.50 |
| INSULIN | activates | concept | 0.50 |
| GENE EXPRESSION | expressed_in | concept | 0.50 |
| Proteins | activates | protein | 0.50 |
| ALZHEIMER'S | regulates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Alzheimer'S Disease | associated_with | disease | 0.95 |
| Beta-Amyloid Oligomers | inhibits | compound | 0.88 |
| NRG1 | regulates | gene | 0.85 |
| Parvalbumin-Containing Interneurons | involved_in | cell_type | 0.85 |
| Nrg1-Erbb4 Signaling | mediates | pathway | 0.85 |
| Reduced Lactate Shuttling | associated_with | mechanism | 0.85 |
| Ketogenic Diet | associated_with | drug | 0.80 |
| Alzheimer | inhibits | disease | 0.70 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.70 |
| COMPLEMENT | regulates | gene | 0.70 |
| AMYLOID | inhibits | gene | 0.70 |
| ALZHEIMER | inhibits | gene | 0.70 |
| Als | regulates | disease | 0.65 |
| JUN | regulates | gene | 0.60 |
| C1Q | associated_with | gene | 0.60 |
| ANXA1 | therapeutic_target | gene | 0.60 |
| NBR1 | therapeutic_target | gene | 0.60 |
| CX3CR1 | associated_with | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| NTS | associated_with | gene | 0.60 |
| NRG1 | expressed_in | gene | 0.60 |
| ERBB4 | expressed_in | gene | 0.60 |
| BDNF | activates | gene | 0.60 |
| TRKB | activates | gene | 0.60 |
| MMP9 | inhibits | gene | 0.60 |
| SST | inhibits | gene | 0.60 |
| MMP3 | inhibits | gene | 0.60 |
| Inflammation | regulates | disease | 0.60 |
| Alzheimer | regulates | disease | 0.60 |
| Neuroinflammation | regulates | disease | 0.60 |
| Stroke | therapeutic_target | disease | 0.60 |
| Aging | therapeutic_target | disease | 0.60 |
| Ischemia | therapeutic_target | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Ms | activates | disease | 0.60 |
| PLCB4 | activates | gene | 0.60 |
| ADAM10 | activates | gene | 0.60 |
| Alzheimer | therapeutic_target | disease | 0.60 |
| Als | associated_with | disease | 0.60 |
| Ms | regulates | disease | 0.60 |
| ANXA1 | protects_against | gene | 0.60 |
| NBR1 | protects_against | gene | 0.60 |
| TNF | protects_against | gene | 0.60 |
| TRKB | regulates | gene | 0.60 |
| GABARAP | inhibits | gene | 0.60 |
| LC3B | associated_with | gene | 0.60 |
| GABARAPL2 | associated_with | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| ERK | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||